Cell study uses Salipro® for nicotinic acetylcholine receptor alpha-7

New research published in Cell used the Salipro platform to uncover how the nicotinic acetylcholine receptor alpha-7 changes into different structural states during signaling. This has implications for drug discovery within a wide range of indications, from neurodegenerative diseases to lung cancer. Congrats to Ryan Hibbs at UT Southwestern and colleagues for their publication!

Publication reference:
C. M. Noviello, et al., Structure and gating mechanism of the a7 nicotinic acetylcholine receptor. Cell 184, 1–14 (2021).